Findings on n-3 Fatty Acid Supplement Health Benefits
The results summarize each of the health outcomes for an experiment where 12,933 subjects received a 1g fish oil supplement daily and 12,938 received a placebo daily. The experiment's duration was 5-years.

Variables
major_cardio_event - Major cardiovascular event. (Primary end point.)
cardio_event_expanded - Cardiovascular event in expanded composite endpoint.
myocardioal_infarction - Total myocardial infarction. (Heart attack.)
stroke - Total stroke.
cardio_death - Death from cardiovascular causes.
PCI - Percutaneous coronary intervention.
CABG - Coronary artery bypass graft.
total_coronary_heart_disease - Total coronary heart disease.
ischemic_stroke - Ischemic stroke.
hemorrhagic_stroke - Hemorrhagic stroke.
chd_death - Death from coronary heart disease.
myocardial_infarction_death - Death from myocardial infraction.
stroke_death - Death from stroke.
invasive_cancer - Invasive cancer of any type. (Primary end point.)
breast_cancer - Breast cancer.
prostate_cancer - Prostate cancer.
colorectal_cancer - Colorectal cancer.
cancer_death - Death from cancer.
death - Death from any cause.
major_cardio_event_after_2y - Major cardiovascular event, excluding the first 2 years of follow-up.
myocardial_infarction_after_2y - Total myocardial infarction, excluding the first 2 years of follow-up.
invasive_cancer_after_2y - Invasive cancer of any type, excluding the first 2 years of follow-up.
cancer_death_after_2y - Death from cancer, excluding the first 2 years of follow-up.
death_after_2y - Death from any cause, excluding the first 2 years of follow-up.
Source
Manson JE, et al. 2018. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. NEJMoa1811403. https://www.nejm.org/doi/full/10.1056/NEJMoa1811403